CORTESI, MICHELA
CORTESI, MICHELA
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer
2019-01-01 Tesei, A.; Cortesi, M.; Pignatta, S.; Arienti, C.; Massimo Dondio, G.; Bigogno, C.; Malacrida, A.; Miloso, M.; Meregalli, C.; Chiorazzi, A.; Carozzi, V.; Cavaletti, G.; Rui, M.; Marra, A.; Rossi, D.; Collina, S.
DEVELOPMENT AND CHARACTERIZATION OF NEW pan-SIGMA RECEPTOR MODULATORS: CHEMICAL, BIOLOGICAL AND PHARMACOLOGICAL STUDIES FOR PRECLINICAL VALIDATION OF NEW THERAPEUTIC TARGETS
2021-02-24 Cortesi, Michela
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents.
2020-01-01 Listro, R.; Stotani, S.; Rossino, G.; Rui, M.; Malacrida, A.; Cavaletti, G.; Cortesi, M.; Arienti, C.; Tesei, A.; Rossi, D.; Di Giacomo, M.; Miloso, M.; Collina, S.
Novel pan sigma receptor modulator exerts strong apoptotic effect in in vitro primary 3D-cell cultures of human glioblastoma
2016-01-01 Pignatta, S; Arienti, C; Zanoni, M; Zamagni, A; Collina, Simona; Tosatto, L; Cortesi, Michela; Nigrisoli, E; Bartolini, D; Faedi, M; Bonafe, M; Tesei, A.
PAN-SIGMA RECEPTOR MODULATORS AS PROMISING ANTICANCER-AGENTS. THE STORY OF RC-106
2017-01-01 Rui, Marta; Rossi, Daniela; Marra, Annamaria; Dondio, Giulio; Tesei, A.; Cortesi, Michela; Collina, Simona
Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer
2022-01-01 Tesei, Anna; Cortesi, Michela; Bedeschi, Martina; Marino, Noemi; Rossino, Giacomo; Listro, Roberta; Rossi, Daniela; Linciano, Pasquale; Collina, Simona
Sigma receptors as endoplasmic reticulum stress "gatekeepers" and their modulators as emerging new weapons in the fight against cancer
2018-01-01 Tesei, Anna; Cortesi, Michela; Zamagni, Alice; Arienti, Chiara; Pignatta, Sara; Zanoni, Michele; Paolillo, Mayra; Curti, Daniela; Rui, Marta; Rossi, Daniela; Collina, Simona
Sigma Receptors: Novel Targets For The Treatment Of Highly Malignant Tumors
2017-01-01 Cortesi, Michela; Pignatta, Sara; Collina, Simona; Rui, Marta; Marra, Annamaria; Tosatto, Luigino; Bartolini, Daniela; Nigrisoli, Evandro; Arienti, Andrea Rocca Alice Zamagni Chiara; Zanoni, Michele; Tesei, Anna
Synthesis and in vitro evaluation of novel pan-SR modulators: Identification of (E)-4-benzyl-1-[3-(naphthalen-2-yl)but-2-en-1-yl]piperidine (RC-106) as potential anticancer agent.
2016-01-01 Rui, Marta; Rossi, Daniela; Marra, Annamaria; Paolillo, Mayra; Curti, Daniela; Tesei, A; Cortesi, Michela; Pace, V; Collina, Simona
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer | 1-gen-2019 | Tesei, A.; Cortesi, M.; Pignatta, S.; Arienti, C.; Massimo Dondio, G.; Bigogno, C.; Malacrida, A.; Miloso, M.; Meregalli, C.; Chiorazzi, A.; Carozzi, V.; Cavaletti, G.; Rui, M.; Marra, A.; Rossi, D.; Collina, S. | |
| DEVELOPMENT AND CHARACTERIZATION OF NEW pan-SIGMA RECEPTOR MODULATORS: CHEMICAL, BIOLOGICAL AND PHARMACOLOGICAL STUDIES FOR PRECLINICAL VALIDATION OF NEW THERAPEUTIC TARGETS | 24-feb-2021 | Cortesi, Michela | |
| Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents. | 1-gen-2020 | Listro, R.; Stotani, S.; Rossino, G.; Rui, M.; Malacrida, A.; Cavaletti, G.; Cortesi, M.; Arienti, C.; Tesei, A.; Rossi, D.; Di Giacomo, M.; Miloso, M.; Collina, S. | |
| Novel pan sigma receptor modulator exerts strong apoptotic effect in in vitro primary 3D-cell cultures of human glioblastoma | 1-gen-2016 | Pignatta, S; Arienti, C; Zanoni, M; Zamagni, A; Collina, Simona; Tosatto, L; Cortesi, Michela; Nigrisoli, E; Bartolini, D; Faedi, M; Bonafe, M; Tesei, A. | |
| PAN-SIGMA RECEPTOR MODULATORS AS PROMISING ANTICANCER-AGENTS. THE STORY OF RC-106 | 1-gen-2017 | Rui, Marta; Rossi, Daniela; Marra, Annamaria; Dondio, Giulio; Tesei, A.; Cortesi, Michela; Collina, Simona | |
| Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer | 1-gen-2022 | Tesei, Anna; Cortesi, Michela; Bedeschi, Martina; Marino, Noemi; Rossino, Giacomo; Listro, Roberta; Rossi, Daniela; Linciano, Pasquale; Collina, Simona | |
| Sigma receptors as endoplasmic reticulum stress "gatekeepers" and their modulators as emerging new weapons in the fight against cancer | 1-gen-2018 | Tesei, Anna; Cortesi, Michela; Zamagni, Alice; Arienti, Chiara; Pignatta, Sara; Zanoni, Michele; Paolillo, Mayra; Curti, Daniela; Rui, Marta; Rossi, Daniela; Collina, Simona | |
| Sigma Receptors: Novel Targets For The Treatment Of Highly Malignant Tumors | 1-gen-2017 | Cortesi, Michela; Pignatta, Sara; Collina, Simona; Rui, Marta; Marra, Annamaria; Tosatto, Luigino; Bartolini, Daniela; Nigrisoli, Evandro; Arienti, Andrea Rocca Alice Zamagni Chiara; Zanoni, Michele; Tesei, Anna | |
| Synthesis and in vitro evaluation of novel pan-SR modulators: Identification of (E)-4-benzyl-1-[3-(naphthalen-2-yl)but-2-en-1-yl]piperidine (RC-106) as potential anticancer agent. | 1-gen-2016 | Rui, Marta; Rossi, Daniela; Marra, Annamaria; Paolillo, Mayra; Curti, Daniela; Tesei, A; Cortesi, Michela; Pace, V; Collina, Simona |